Skip to search formSkip to main contentSkip to account menu

madurahydroxylactone

Known as: MHL cpd 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Three algorithms of first-order reliability method (FORM) using steepest descent search direction are compared to evaluate the… 
2017
2017
FtsZ, a bacterial cell-division protein, is an attractive antibacterial target. In the screening for an inhibitor of… 
Review
2017
Review
2017
Multidrug-resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) have become a significant global health… 
2013
2013
RATIONALE The fate of drug delivery systems (DDSs) in vivo is a widely discussed question. Matrix-assisted laser desorption… 
2010
2010
Madurahydroxylactone (MHL), a secondary metabolite with antibacterial activity was evaluated for its suitability to generate… 
2007
2007
ABSTRACT A series of 29 madurahydroxylactone derivatives was evaluated for dual inhibition of human immunodeficiency virus type 1… 
2007
2007
Thiosemicarbazones of the microbial metabolite madurahydroxylactone, a polysubstituted benzo[a]naphthacenequinone, have been… 
2002
2002
1999
1999
Madurahydroxylactone is a secondary metabolite from Nonomuria rubra (former Actinomadura rubra) with in vitro activity against…